New β-blocker: Prolonged reduction in high blood pressure with β1 antisense oligodeoxynucleotides

Hypertension

Volumn 35, Issue 1 II, 2000, Pages 219-224

  Zhang, Yuan Clare ^a   Kimura, Birgitta ^a   Shen, Leping ^a   Phillips, M Ian ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

Antisense; Blood pressure; Kidney; Renin angiotensin system; 1 adrenergic receptors

Indexed keywords

5 [2 [[2 HYDROXY 3 [4 (1 METHYL 4 TRIFLUOROMETHYL 2 IMIDAZOLYL)PHENOXY]PROPYL]AMINO]ETHOXY]SALICYLAMIDE; ALPRENOLOL; ANGIOTENSIN ANTAGONIST; ANTISENSE OLIGODEOXYNUCLEOTIDE; BETA 1 ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CYANOIODOPINDOLOL; DIOLEOYLPHOSPHATIDYLETHANOLAMINE; LIPOSOME; MESSENGER RNA; PREPRORENIN; TRIMETHYLAMMONIUM SALT DERIVATIVE;

ANGIOTENSIN BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL TISSUE; BLOOD PRESSURE; CONFERENCE PAPER; CONTROLLED STUDY; DRUG EFFECT; GENE TARGETING; HEART MUSCLE CONTRACTILITY; HYPERTENSION; MALE; NONHUMAN; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL; RECEPTOR DENSITY; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SPONTANEOUSLY HYPERTENSIVE RAT;

EID: 0033954747     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.hyp.35.1.219     Document Type: Conference Paper

References (20)

1. Man in't Veld AJ, van den Meiracker AH, Schalekamp MA. Do betablockers really increase peripheral vascular resistance? Review of the literature and new observations under basal conditions. Am J Hypertens. 1988;1:91-96.
2. Phillips MI, Wielbo D, Gyurko R. Antisense inhibition of hypertension: a new strategy for renin-angiotensin candidate genes. Kidney Int. 1994; 46:1554-1556.
3. 1-adrenoceptor mRNA in a single dose produces a profound and prolonged reduction in high-Wood pressure in spontaneously hypertensive rats. Circulation. In press.
4. Holmer SR, Kaissling B, Putnik K, Pfeifer M, Kramer BK, Riegger GA, Kurtz A. Beta-adrenergic stimulation of renin expression in vivo. J Hypertens. 1997;15:1471-1479.
5. Blumenfeld JD, Sealey JE, Mann SJ, Bragat A, Marion R, Pecker MS, Sotelo J, August P, Pickering TG, Laragh JH. Beta-adrenergic receptor blockade as a therapeutic approach for suppressing the renin-angiotensin-aldosterone system in normotensive and hypertensive subjects. Am J Hypertens. 1999;12:451-459.
6. Buhler FR. Antihypertensive treatment according to age, plasma renin and race. Drugs. 1988;35:495-503.
7. Man in't Veld AJ, Schalekamp MA. Haemodynamic consequences of intrinsic sympathomimetic activity in relation to changes in plasma renin activity and noradrenaline during beta-blocker therapy for hypertension. Postgrad Med J. 1983;59(suppl 3):140-158.
8. Machida CA, Bunzow JR, Searles RP, Van TH, Tester B, Neve KA, Teal P, Nipper V, Civelli O. Molecular cloning and expression of the rat beta-1-adrenergic receptor. J Biol Chem. 1990;265:12960-12965.
9. Baker SP, Pitha J. Irreversible blockade of beta adrenoreceptors and their recovery in the rat heart and lung in vivo. J Pharmacol Exp Ther 1982;220:247-251.
10. Matthews JM, Molenaar P, Summers RJ. Beta-adrenoceptor subtypes in the atrioventricular conducting system and myocardium of spontaneously hypertensive rats: effects of angiotensin-converting enzyme inhibition by perindopril. J Cardiovasc Pharmacol. 1994;23:691-697.
11. Jo H, Yang EK, Lee WJ, Park KY, Kim HJ, Park JS. Gene expression of central and peripheral renin-angiotensin system components upon dietary sodium intake in rats. Regul Pept. 1996;67:115-121.
12. Phillips MI, Kimura B. Brain angiotensin in the developing spontaneously hypertensive rat. J Hypertens. 1988;6:607-612.
13. Yang JP, Huang L. Overcoming the inhibitory effect of serum on lipofection by increasing the charge ratio of cationic liposome to DNA. Gene Ther. 1997;4:950-960.
14. Templeton NS, Lasic DD, Frederik PM, Strey HH, Roberts DD, Pavlakis GN. Improved DNA: liposome complexes for increased systemic delivery and gene expression. Nat Biotechnol. 1997;15:647-652.
15. Summers RJ, Stephenson JA, Kuhar MJ. Localization of beta adrenoceptor subtypes in rat kidney by light microscopic autoradiography. J Pharmacol Exp Ther. 1985;232:561-569.
16. Holmer S, Rinne B, Eckardt KU, Le HM, Schricker K, Kaissling B, Riegger G, Kurtz A. Role of renal nerves for the expression of renin in adult rat kidney. Am J Physiol. 1994;266:F738-F745.
17. Phillips MI, Ambuhl P, Gyurko R. Antisense oligonucleotides for in vivo studies of angiotensin receptors. Adv Exp Med biol. 1996;396:79-92.
18. Phillips MI. Antisense inhibition and adeno-associated viral vector delivery for reducing hypertension. Hypertension. 1997;29:177-187.
19. Chen M, Schnermann J, Smart AM, Brosius FC, Killen PD, Briggs JP. Cyclic AMP selectively increases renin mRNA stability in cultured juxtaglomerular granular cells. J Biol Chem. 1993;268:24138-24144.
20. Yang JP, Huang L. Time-dependent maturation of cationic liposome-DNA complex for serum resistance. Gene Ther. 1998;5: 380-387.